Aβ	Amyloid β
ACEA	Arachidonyl-2-chloroethylamide
AD	Alzheimer’s disease
ALS	Amyotrophic lateral sclerosis
AMPA	α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
BBB	Blood–brain barrier
BDNF	Brain-derived neurotrophic factor
CNS	Central nervous system
CRAC	Calcium release-activated calcium
CREB	Cyclic adenosine monophosphate response element-binding protein
DAG	Diacylglycerol
DHP	Dihydropyridines
DMT	Disease-modifying therapies
EAE	Experimental autoimmune encephalomyelitis
GABA	Gamma-aminobutyric acid
GFAP	Glial fibrillary acidic protein
GPCR	G-protein coupled receptors
DAG	Diacylglycerol
HD	Huntington’s disease
IP3	Inositol-3-phosphate
IP3R	Inositol-3-phosphate receptor
KA	Kainate
KOR	κ Opioid receptor
MBP	Myelin basic protein
MS	Multiple sclerosis
NF-κB	Nuclear factor kappa-light-chain-enhancer of activated B cells
NAADP	Nicotinic acid adenine dinucleotide phosphate
NMDA	N-methyl-d-aspartate
NO	Nitric oxide
OPC	Oligodendrocyte precursor cell
PD	Parkinson’s disease
PPMS	Primary progressive multiple sclerosis
ROS	Reactive oxygen species
RRMS	Relapsing-remitting multiple sclerosis
RyR	Ryanodine receptor
S1PR	Sphingosin-1-phosphate receptor
SMA	Spinal muscle atrophy
SOCE	Store-operated calcium entrance
STIM1/2	Stromal interaction molecule 1/2
SPMS	Secondary progressive multiple sclerosis
TPC	Two-pore channels
TRP	Transient receptor potential
TRPA	Transient receptor potential ankyrin channel
TRPC	Transient receptor potential canonical channel
TRPM	Transient receptor potential melastatin channel
TRPML	Transient receptor potential mucolipin channel
TRPP	Transient receptor potential polycystic channel
TRPV	Transient receptor potential vanilloid channel
VDAC	Voltage-dependent anion channels
VGCC	Voltage-gated calcium channels